Kazankov et al. reported that soluble CD163 (sCD163) levels increased in association with the fibrosis stage in patients with chronic hepatitis C, suggesting that sCD163 can be useful as a marker of liver fibrosis21. The gene discussed is CD163; the disease is chronic hepatitis C virus infection.